可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Tsimikas S. Drug-eluting stents and late adverse clinical outcomes lessons learned, lessons awaited[J]. J Am Coll Cardiol, 2006, 47(10):2112-2115.
[2]Rodriguez AE, Mieres J, Fernandez-Pereira C, et al. Coronary stent thrombosis in the current drug-eluting stent era: insights from the ERACI III trial[J]. J Am Coll Cardiol, 2006, 47(1):205-207.
[3] Cheneau E, Leborgne L, Mintz GS, et al. Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study[J]. Circulation, 2003, 108(1):43-47.
[4]Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study[J]. J Am Coll Cardiol, 2005, 45(7):995-998.
[5]Chieffo A, Stankovic G, Bonizzoni E, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main [J]. Circulation, 2005, 111(6):791-795.
[6]Gao Z, Yang YJ, Xu B, et al. Is adjunctive balloon postdilatation necessary with drug-eluting stents? One center experience in Chinese patients[J]. Chin Med J (Engl), 2008, 121(6):513-517.